Three University of Rhode Island (“URI”) students appeal from a district court order dismissing their federal antitrust, equal protection, and due process claims against URI, its Board of Governors, three URI officials, and URI’s student-health insurer, Life Insurance Company of North America (“LINA”). Finding no error, we affirm the district court judgment.
I
BACKGROUND
As a precondition to reregistering each semester, URI requires all full-time undergraduate students to pay a fixed fee for the right to use URI’s on-campus, walk-in medical clinic, University Health Services (“UHS”). 1 All students who pay the UHS clinic fee must also carry supplemental health insurance coverage for certain medical services, such as x-rays, lab tests and gynecological tests, that are available through UHS. Two supplemental insurance options are available. First, the student may obtain supplemental insurance through LINA, a private health care underwriter which URI sponsors as its “default” insurer. LINA purportedly “dovetails” its supplemental coverage so that the insured student pays an annual premium that minimizes duplicative coverage; that is, it lessens the risk that the LINA premium and the UHS clinic fee will reflect redundant coverage for the same medical procedures. 2 As a second option, students may secure “comparable [supplemental] coverage” from an off-campus health care insurer of their choice, except that URI does not consider either Rhode Island Blue Cross or Rhode Island-based HMOs “comparable coverage.” Students who do not opt out of the LINA “default” coverage by a specified deadline are automatically billed for the annual LINA premium, and cannot re-register for the following semester until the LINA premium has been paid. The automatic “default” scheme notwithstanding, only about 40% of the students who pay the UHS clinic fee insure through LINA.
Appellants initiated this class action in federal district court against URI and LINA in January 1992. The amended complaint alleges that the practice of conditioning continued matriculation at URI on payment of the UHS clinic fee and/or the LINA supplemental insurance premium violates the Sherman Antitrust Act, 15 U.S.C. § 1 (1993), as well as the equal protection and due process guarantees under the United States Constitution. Following minimal discovery, URI and LINA moved to dismiss pursuant to Fed.R.CivJP. 12(b)(6),
3
and the district court dismissed all claims.
Lee v. Life Ins. Co. of N.A.,
II
DISCUSSION
A. The Antitrust “Tying” Claim
Appellants challenge the dismissal of their claim that the URI health eare-
Appellants claim three “product” tie-ins: (1) between a university education (URI) and health insurance coverage (LINA); (2) between health care services (UHS) and health insurance coverage (LINA); and (3) between a university education (URI) and health care services (UHS).
6
We agree with the district court however, that appellants failed to allege
any
“tie-in” claim upon which relief could be granted. In particular, appellants failed to advance a colorable claim as to an
indispensable
element: that URI had AEP in the relevant tying markets (university education and health care services). AEP or “market power” is the demonstrated ability of a seller “to force a purchaser to do something that he would not do in a competitive market.”
Jefferson Parish Hosp. Dist. No. 2 v. Hyde,
Appellants can assert no colorable claim that URI holds AEP either in the “tying” market for a university education or in the “tying” market for health care services. URI competes for new undergraduate and graduate students on a regional and national level with dozens of universities and colleges. 7 Although URI obviously is a “unique” institution in a colloquial sense, appellants cannot claim that other institutions of higher education do not or cannot provide “functionally similar” educational offerings to potential URI applicants. Cf. id. at 798 (brand name alone does not establish product “uniqueness” necessary for AEP). And, of course, absent AEP in the university-education market it is a virtual given that URI cannot enjoy AEP in the student health care business.
Appellants attempt to circumvent URI’s evident lack of AEP in the two relevant tying markets by contriving a so-called
Kodak
“lock-in.”
Kodak
involved distinct products: Kodak copiers (the “lock-in” product), Kodak copier replacement parts (the tying product), and Kodak copier servicing and repair (the tied product). In 1985, Kodak began to confine sales of Kodak copier parts to Kodak copier owners who contracted to have their copiers
serviced
by Kodak, rather than by Kodak’s servicing competitors (“ISOs”).
Kodak,
— U.S. at-,
•By reason of Kodak’s very small market share in copier sales, the parties had stipulated that Kodak had no AEP in the copier market
(assuming
copier sales to be the relevant “tying” market), and hence, no unlawful “tie” could exist between Kodak copiers and Kodak parts-servicing.
Id.
at-n. 10,
The Court rejected Kodak’s
per se
“cross-elasticity of demand” theory, identifying
two
different fact patterns which, if borne out by the evidence, might support a reasonable inference that parts and servicing contract price increases would not necessarily cause Kodak to lose copier sales. Under the first scenario, the evidence might demonstrate that a substantial number of consumers, at the time of their original copier purchases, would not enjoy cost-efficient
8
access to the difficult-to-acquire pricing information needed to evaluate the total “life-cycle” cost of the entire Kodak “package” — namely, the price of the copier, likely replacement parts, and product-lifetime servicing.
Id.
at- -,
Appellants attempt to shoehorn their allegations into this
Kodak
“derivative aftermarket” mold, by proposing the following comparative model:
first-semester
matriculation at URI serves as the “lock-in” product, as did the Kodak copier; subsequent semesters at URI serve as the tying product, as did Kodak replacement parts; and health clinic services and health insurance coverage represent the tied products. Of course, URI, like Kodak, might contend, on summary judgment or at trial, that its lack of AEP in the locked-in product market (“sales” of first-semester university education) creates a “cross-elasticity of demand,” which would prevent health clinic fees and LINA supplemental insurance premiums from being increased to uncompetitive levels. Nevertheless, because
Kodak
was a
summary judgment
case, rather than a Rule 12(b)(6) case, appellants argue that they did enough to withstand URI’s motion to dismiss simply by alleging the existence of
unspecified
“information” and “switching” costs, which must be credited for Rule 12(b)(6) purposes.
See Rumford Pharmacy, Inc. v. City of East Providence,
Appellants challenge the district court ruling that their “information cost” allegations were insufficient to defeat the motion to dismiss. First, appellants argue that URI cannot posit a “cross-elasticity of demand” in the present context because the prices charged for health clinic services and insurance premiums are too insignificant in relation to tuition and other university-education costs to be considered a meaningful factor in determining whether potential applicants for admission will attend URI or some other university. Alternatively, appellants argue that URI would bear the burden of proof on this issue at trial, and that on appeal it has not pointed to supportive evidence of consumer “sophistication.”
Appellants exaggerate the role that summary-judgment burden shifting played in the
Kodak
analysis.
Kodak
simply pointed out that summary judgment was not
yet
in order on Kodak’s “cross-elasticity of demand” theory (1) in light of the plaintiff ISOs’ proffer on “information
costs”
— i.e.,
readily inferable
expenses associated with accumulating technical information relating to the costs of equipment, parts, and servicing over the lifetime of a “complex durable goods” item,
and
(2) in the absence of any conclusive evidence from Kodak that a substantial number of purchasers
actually
make accurate prepur-chase assessments of the life-cycle “package” price of their Kodak copiers. Thus, the Court neither discussed any reallocation of burdens of proof at trial, nor in any way intimated a
shift
in the evidentiary burden of proof on the factual issues of “information costs” and “lock-in.”
See, e.g., Jefferson Parish,
Second, appellants argue that it is impossible to allege “information costs” because potential URI applicants cannot know or predict their future URI health clinic fees and LINA insurance premiums with any precision, since URI and LINA reserve the right to increase these charges each year. But appellants mistake the focus of the Court’s concerns about the “information costs” in Kodak.
In
Kodak,
the information required by the customer pertained to the life-cycle pricing of a Kodak copier “package,” information so patently “difficult and costly” to come by that it spontaneously gave rise to a reasonable inference that unsophisticated consumers would not have the information needed to evaluate their options at the time they made their decision to purchase a Kodak copier.
Kodak,
— U.S. at-,
The district court further ruled that appellants failed to state an' actionable claim that they were “locked in”; that is, they failed to plead actual costs associated with switching from URI after their first semester. Although appellants now assert that they can amend their complaint to allege such costs, we conclude that further amendment to allege specific “switching costs” would be futile.
See University of Rhode Island v. AW. Chesterton Co.,
First, there is an important distinction between
Kodak
and the present case.
Kodak
Second, the
timing
of the “lock-in” at issue in
Kodak
was central to the Supreme Court’s decision. Unsophisticated Kodak copier owners were destined for “lock-in”
from the moment they purchased their Kodak copiers.
At the time current Kodak copier owners bought their copiers, Kodak had not yet conditioned its sale of replacement parts on the purchase of Kodak servicing, and its later-announced policy to that effect was made applicable both to prospective
and existing
Kodak copier owners. Had previous customers known, at the time they bought their Kodak copiers, that Kodak would implement its restrictive parts-servicing policy, Kodak’s “market power,”
ie.,
its leverage to induce customers to purchase Kodak servicing, could only havé been as significant as its AEP in the
copier market,
which was stipulated to be inconsequential or nonexistent.
See Kodak,
— U.S. at--,
B. The “Due Process” and “Equal Protection” Claims
Appellants attempt to raise two vaguely articulated constitutional challenges to the URI health services-insurance scheme. First, they argue that URI’s conditioning of continued matriculation on the payment of a health clinic fee violates their constitutional right to procedural due process, by depriving them of a property interest (fees and premiums), and a liberty-privacy interest (the alleged right to retain a physician of one’s choice). Unsurprisingly, appellants cite no case authority for either contention, nor have we found any.
11
Appellants purchased a
Second, appellants argue that the URI “package” infringes their constitutional right to equal protection of the laws because male and female students matriculating at URI must pay the same health care fees, even though male students will not utilize the UHS gynecological services. The district court aptly found that appellants failed to allege that URI imposed this unitary scheme with any discriminatory animus aimed at male students.
See Nieves v. University of Puerto Rico,
Affirmed.
Notes
. Graduate students are not required to pay the UHS clinic fee, provided they have health insurance coverage that meets URI's requirements.
. LINA coverage requires the student to present for treatment at UHS in the first instance, pending possible referral to an outside health care provider.
. Appellants’ motion for class certification was stayed pending disposition of appellees’ motions to dismiss.
. At the same time, the district court declined to exercise jurisdiction over several pendent state-law claims, see 28 U.S.C. § 1367(c)(3) (1993). Cf. infra note 11.
. The tie-in must also affect a substantial volume of commerce in the lied market,
see Kodak,
— U.S. at-,
. Notwithstanding certain misgivings, we further assume,
without deciding,
that the amended complaint adequately pleads two other essential "tying” claim elements. These assumptions merely facilitate clearer focus on the core deficiency in appellants' antitrust claim. First, we presume that the products at issue are distinct,
i.e.,
that each is distinguishable by consumers in the relevant market, and that there would be sufficient consumer demand for each
individual
product, and not merely as part of an integrated product "package.”
See Jefferson Parish Hosp. Dist. No. 2 v. Hyde,
. As of 1991, for example, Rhode Island residents comprised only 56% of the URI student body.
. The Court noted that even assuming readily available price information, consumers rationally might decide not to investigate life-cycle costs if investigation would prove more costly than the potential savings. Id.,-U.S. at-,
. The Kodak Court elaborated on the complexity of the ‘'information” needed to make an informed investment:
In order to arrive at an accurate price, a consumer must acquire a substantial amount of raw data and undertake sophisticated analysis. The necessary information would include data on price, quality, and availability of products needed to operate, upgrade, or enhance the initial equipment, as well as service and repair costs, including estimates of breakdown frequency, nature of repairs, price of service and parts, length of "down-time” and losses incurred from down-time.
Much of this information is difficult — some of it is impossible — to acquire at the time of purchase. During the life of a product, companies may change the service and parts prices, and develop products with more advanced features, a decreased need for repair, or new warranties. In addition, the information is likely to be customer specific; lifecycle costs will vary from customer to customer with the type of equipment, degrees of equipment use, and costs of down-time.
Kodak,-U.S. at-,
. Considering the recent hyperinflationary trends in the health care industry as a whole, UHS clinic fees have increased at fairly predictable increments since 1987: 1987-88 ($179); 1988-89 ($188); 1989-90 ($200.50); 1990-91 ($227); 1991-92 ($248); 1992-93 ($312). LINA premiums have increased comparably over the same period, from $158 in 1987-88 to $369 in 1992-93. The record contains no evidence that prospective URI applicants would have great difficulty gaining access to this information from any number of reliable sources (e.g., URI application materials, URI admissions officials, past or current URI students, college entrance source books). Nor do appellants suggest that URI had any incentive to conceal the scope of past price increases. On the billing invoices it mails to students, URI routinely individualizes its charges for registration, tuition, UHS fees, LINA premiums, and taxes.
. The district court interpreted'appellants' complaint as alleging claims based on substantive due process and the right to contract.’ Appellants concede that their "cumbersome briefing” contributed to this understanding, yet did not move for reconsideration.
See Vanhaaren v. State Farm Mut. Auto. Ins. Co.,
Inexplicably, appellants continue to urge that Rhode Island law disempowered URI from entering the "business” of health care and insurance, and that the LINA policies were merely a fraud or sham affording students no actual coverage. Although these allegations might be material to appellants'
ultra vires
claim under state law, which the district court dismissed without prejudice,
cf. Boston Envtl. Sanitation Inspectors Ass’n
v.
City of Boston,
